Description: CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.
Home Page: www.solosendoscopy.com
Boston/Dedham Commerce Park
Boston,
MA
02136
United States
Phone:
617 360 9700
Officers
| Name | Title |
|---|---|
| Mr. Dom L. Gatto | Pres, CEO, Sec., Treasurer & Chairman |
| Mr. Fred V. Schiemann CPA | CFO & Director |
| Mr. Gerald Schwebel | Operations Mang. |
| Ms. J. Amanda Segersten | Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.4077 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.1151 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |